Economic information and modeling reportBudget impact model
Cost assumptions
2 evidence topics · 1 source
Saroglitazar
Primary biliary cholangitis
- Manufacturer
- Zydus Therapeutics
- Regulatory submission
- NDA submitted by May 2026
- Last updated
Primary biliary cholangitis
Economic information and modeling reportBudget impact model
2 evidence topics · 1 source